{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:00:02Z","timestamp":1778814002014,"version":"3.51.4"},"reference-count":73,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4086,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2004.00167.x","type":"journal-article","created":{"date-parts":[[2004,6,24]],"date-time":"2004-06-24T09:02:03Z","timestamp":1088067723000},"page":"612-624","source":"Crossref","is-referenced-by-count":129,"title":["Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections"],"prefix":"10.1155","volume":"58","author":[{"given":"R.","family":"Herbrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2004,6,24]]},"reference":[{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CMR.9.4.499","article-title":"Epidemiology of nosocomial fungal infections","volume":"9","author":"Fridkin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2004-824903","article-title":"Invasive pulmonary aspergillosis","volume":"25","author":"Herbrecht","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/322606","article-title":"Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997","volume":"33","author":"McNeil","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB8|cit8","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Marty","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi","volume":"37","author":"Husain","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2141.1997.3983214.x","article-title":"Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases: GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto)","volume":"99","author":"Pagano","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB13|cit13","volume-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30","author":"Sanglard","year":"2002"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1128\/AAC.47.10.3149-3154.2003","article-title":"Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States","volume":"47","author":"Ostrosky-Zeichner","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/46.2.229","article-title":"A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)","volume":"46","author":"Manavathu","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1128\/AAC.45.10.2862-2864.2001","article-title":"In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans","volume":"45","author":"Pfaller","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB17|cit17","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Pfaller","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","article-title":"Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi","volume":"41","author":"Diekema","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","article-title":"Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.46.5.1352-1356.2002","article-title":"In vitro and in vivo activities of posaconazole against Coccidioides immitis","volume":"46","author":"Gonzalez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB24|cit24","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Ezzet","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.44.3.780-782.2000","article-title":"Efficacy of SCH56592 in a rabbit model of invasive aspergillosis","volume":"44","author":"Kirkpatrick","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.41.7.1504","article-title":"Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus","volume":"41","author":"Oakley","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB27|cit27","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Imai","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.41.7.1558","article-title":"Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis","volume":"41","author":"Lutz","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.43.2.322","article-title":"Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice","volume":"43","author":"Connolly","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/AAC.46.7.2310-2312.2002","article-title":"In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB31|cit31","volume-title":"38th Interscience Conference of Antimicrobial Agents in Chemotherapy; September 24-27","author":"Al-Abdely","year":"1998"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB32|cit32","volume-title":"13th European Congress of Clinical Microbiology and Infectious Diseases; May 10-13","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/AAC.47.9.2788-2795.2003","article-title":"Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults","volume":"47","author":"Courtney","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB34|cit34","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB35|cit35","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, September 14-17","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2125.2003.01977.x","article-title":"Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults","volume":"57","author":"Courtney","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB37|cit37","article-title":"The oral bioavailability of posaconazole in fasted healthy subjects: basis for clinical dosage recommendations","author":"Ezzet","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB38|cit38","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Ezzet","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB39|cit39","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Ullmann","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB40|cit40","volume-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30","author":"Krieter","year":"2002"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB41|cit41","unstructured":"Janssen Pharmaceutica Products 2002"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB42|cit42","unstructured":"Pfizer Inc 2002"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB43|cit43","volume-title":"42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30","author":"Wexler","year":"2002"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-200038020-00002","article-title":"Effects of the antifungal agents on oxidative drug metabolism: clinical relevance","volume":"38","author":"Venkatakrishnan","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002018-199818020-00001","article-title":"Systemic antifungal agents: drug interactions of clinical significance","volume":"18","author":"Albengres","year":"1998","journal-title":"Drug Saf"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB46|cit46","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB47|cit47","volume-title":"3rd European Congress of Clinical Microbiology and Infectious Diseases; May 10-13","author":"Courtney","year":"2000"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB48|cit48","volume-title":"Annual Meeting of American Association of Pharmaceutical Scientists; October 29-November 2","author":"Courtney","year":"2000"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB49|cit49","volume-title":"13th European Congress of Clinical Microbiology and Infectious Diseases; May 10-13","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB50|cit50","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Sansone","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB51|cit51","volume-title":"41st Interscience Conference on Antimicrobial Agents and Chemotherapy; December 16-19","author":"Courtney","year":"2001"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/AAC.48.3.804-808.2004","article-title":"Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men","volume":"48","author":"Courtney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB53|cit53","volume-title":"13th European Congress of Clinical Microbiology and Infectious Diseases; May 10-13","author":"Courtney","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB54|cit54","volume-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20","author":"Hachem","year":"2000"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB55|cit55","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Greenberg","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB56|cit56","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Negroni","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB57|cit57","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Pitisuttithum","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB58|cit58","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Restrepo","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB59|cit59","first-page":"195a","article-title":"Posaconazole for treatment of invasive aspergillosis in patients who are refractory to or intolerant of conventional therapy: an externally controlled blinded trial","volume":"102","author":"Walsh","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB60|cit60","volume-title":"43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17","author":"Segal","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB61|cit61","volume-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20","author":"Catanzaro","year":"2000"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB62|cit62","volume-title":"41st Meeting of the Infectious Disease Society of America; October 9-12","author":"Anstead","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB63|cit63","volume-title":"15th Congress of the International Society for Human and Animal Mycosis; May 25-29","author":"Anstead","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB64|cit64","volume-title":"15th Congress of the International Society for Human and Animal Mycosis; May 25-29","author":"Lewis","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB65|cit65","volume-title":"15th Congress of the International Society for Human and Animal Mycosis; May 25-29","author":"Negroni","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB66|cit66","volume-title":"13th European Congress of Clinical Microbiology and Infectious Diseases; May 10-13","author":"Al-Abdely","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/375075","article-title":"Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy","volume":"36","author":"Tob\u00f3n","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB68|cit68","volume-title":"Joint Meeting of the 9th Congress of the European Confederation of Medical Mycology and the 7th Trends in Invasive Fungal Infections; September 28-October 1","author":"Tissot-Dupont","year":"2003"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10096-002-0828-8","article-title":"Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B","volume":"21","author":"Herbrecht","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB70|cit70","article-title":"Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant patient","author":"Herbrecht","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1086\/340522","article-title":"Treatment of Scedosporium apiospermum brain abscesses with posaconazole","volume":"34","author":"Mellinghoff","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB72|cit72","volume-title":"40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20","author":"Nieto","year":"2000"},{"key":"10.1111\/j.1368-5031.2004.00167.x-BIB73|cit73","volume-title":"39th Interscience Conference on Antimicrobial Agents in Chemotherapy; September 26-29","author":"Skiest","year":"1999"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2004.00167.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2004.00167.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:03:20Z","timestamp":1643349800000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2004.00167.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,24]]},"references-count":73,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00167.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6,24]]}}}